anmelden
UBS Global Gender Equality ETF hCHF
UBS Global Gender Equality ETF hCHF Kurs - 1 Jahr
SIX SX| Emittent | UBS Asset Management |
| Auflagedatum | 19.12.2017 |
| Kategorie | Aktien |
| Fondswährung | CHF |
| Benchmark | Solactive Equileap Gb Gd Ey 100 NR USD |
| Ausschüttungsart | Ausschüttend |
| Total Expense Ratio (TER) | 0,23 % |
| Fondsgröße | 179.498.742,29 |
| Replikationsart | Physisch vollständig |
| Morningstar Rating | - |
Anlageziel UBS Global Gender Equality UCITS ETF hCHF dis
So investiert der UBS Global Gender Equality UCITS ETF hCHF dis: The Fund objective is to track the performance of the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index.The investment policy of the Fund is to seek to track the performance of the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index (or any other index determined by the Directors from time to time to track substantially the same market as the Solactive Equileap Global Gender Equality 100 Leaders Net Total Return Index and which is considered by the Directors to be an appropriate index for the Fund to track) as closely as possible, while seeking to minimise as far as possible the difference in performance between the Fund and the Index.
Der UBS Global Gender Equality UCITS ETF hCHF dis gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2H5CG
| 3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2026 | |
|---|---|---|---|---|---|---|
| Performance | +2,56 % | +3,37 % | +13,75 % | +35,08 % | +33,51 % | +5,53 % |
| Outperformance ggü. Kategorie | +0,55 % | -0,46 % | +0,38 % | +0,68 % | -3,86 % | -3,28 % |
| Max Verlust | - | - | -9,33 % | -14,04 % | -23,27 % | - |
| Kurs | - | - | - | - | - | 18,08 CHF |
| Hoch | - | - | 17,86 CHF | - | - | - |
| Tief | - | - | 16,01 CHF | - | - | - |
Kennzahlen ISIN: IE00BDR5H305
| Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
|---|---|---|---|---|
| Volatilität | 7,72 % | 10,28 % | 12,12 % | |
| Sharpe Ratio | +1,42 | +0,92 | +0,47 |
Zusammensetzung WKN: A2H5CG
Größte Positionen ISIN: IE00BDR5H305
| Name | ISIN | Marktkapitalisierung | Gewichtung |
|---|---|---|---|
| Keysight Technologies Inc | US49338L1035 | 47.186.199.196 € | 1,92 % |
| Illumina Inc | US4523271090 | 24.683.283.804 € | 1,64 % |
| Merck & Co Inc | US58933Y1055 | 275.239.970.282 € | 1,49 % |
| Alcoa Corp | US0138721065 | 10.144.192.081 € | 1,47 % |
| Biogen Inc | US09062X1037 | 26.581.370.186 € | 1,42 % |
| National Bank of Canada | CA6330671034 | 56.576.747.694 € | 1,36 % |
| Johnson & Johnson | US4781601046 | 532.403.591.294 € | 1,36 % |
| Canadian Imperial Bank of Commerce | CA1360691010 | 98.288.666.962 € | 1,35 % |
| SSE PLC | GB0007908733 | 35.321.284.218 € | 1,35 % |
| Standard Chartered PLC | GB0004082847 | 53.820.542.798 € | 1,33 % |
| Summe Top 10 | 14,68 % | ||
Ausschüttungen WKN: A2H5CG
| Zahlungstermine | Betrag |
|---|---|
| 09.02.2026 | 0,13 CHF |
| Total | 0,13 CHF |
| 06.02.2025 | 0,04 CHF |
| 28.07.2025 | 0,22 CHF |
| Total | 0,26 CHF |
| 01.02.2024 | 0,11 CHF |
| 07.08.2024 | 0,23 CHF |
| Total | 0,34 CHF |
| 01.02.2023 | 0,13 CHF |
| 08.08.2023 | 0,25 CHF |
| Total | 0,37 CHF |
| 01.02.2022 | 0,16 CHF |
| 01.08.2022 | 0,24 CHF |
| Total | 0,39 CHF |